Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Fish and Richardson
US Department of Justice
Argus Health
Daiichi Sankyo
Federal Trade Commission

Generated: December 15, 2017

DrugPatentWatch Database Preview

IOPAMIDOL-300 Drug Profile

« Back to Dashboard

When do Iopamidol-300 patents expire, and when can generic versions of Iopamidol-300 launch?

Iopamidol-300 is a drug marketed by Abbvie, Cook Imaging, Fresenius Kabi Usa, and Hospira. and is included in seven NDAs.

The generic ingredient in IOPAMIDOL-300 is iopamidol. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iopamidol profile page.
Drug patent expirations by year for IOPAMIDOL-300

Medical Subject Heading (MeSH) Categories for IOPAMIDOL-300

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
AbbvieIOPAMIDOL-300iopamidolINJECTABLE;INJECTION074638-001Apr 30, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
HospiraIOPAMIDOL-300 IN PLASTIC CONTAINERiopamidolINJECTABLE;INJECTION074637-001Apr 3, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
HospiraIOPAMIDOL-300iopamidolINJECTABLE;INJECTION074898-003Dec 30, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Cook ImagingIOPAMIDOL-300iopamidolINJECTABLE;INJECTION074881-003Jul 28, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaIOPAMIDOL-300iopamidolINJECTABLE;INJECTION074679-002Apr 2, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
HospiraIOPAMIDOL-300 IN PLASTIC CONTAINERiopamidolINJECTABLE;INJECTION074636-003Dec 30, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
HospiraIOPAMIDOL-300iopamidolINJECTABLE;INJECTION075005-002Feb 24, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Army
Daiichi Sankyo
US Department of Justice
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: